This Is Sick: Jew Run Goldman Sachs States That Curing Diseases Is NOT For Good Business! Now We Know WHY Cures For Diseases Such As Cancer Are Never Made Public!

I got a message the other day that a long time colleague and friend from years back had recently died of complications due to his fight against Colon Cancer..... Apparently he went through all of the bullshit of both Chemotherapy and Radiation "treatments" and eventually succumbed to that "disease" after years of enduring pain and extreme hardship...... I was of course saddened by the news, and once again after finding out how much he had to endure from the bullshit "treatments" rather than being actually supplied with an actual cure for Cancer, I knew that a new article exposing the fraud of Cancer and those so called "Cancer treatments" that never ever cure the disease, was needed at this blog.....I found the following article, thanks to a link through John De Nugget's website, at www.johndenugent.com, that shows how truly sickening the bastards behind the Cancer "industry" and the criminals behind "big Pharma" really are!  For according to the following report, from the ARS Technica website, at www. the Jewish pricks behind Goldman Sachs recently stated that actually curing patients of their diseases is NOT profitable (!) and as they put it "not a sustainable business model" (!!).... Here in fact is that most interesting article for everyone to see for themselves, and yes I absolutely do have my own thoughts and comments to follow:“Is curing patients a sustainable business model?” Goldman Sachs analysts ask

Analyst report notes that Gilead’s hep C cure will make less than $4 billion this year.

BETH MOLE -  4/12/2018, 4:45 PM“IOne-shot cures for diseases are not great for business—more specifically, they’re bad for longterm profits—Goldman Sachs analysts noted in an April 10 report for biotech clients, first reported by CNBC.The investment banks’ report, titled “The Genome Revolution,” asks clients the touchy question: “Is curing patients a sustainable business model?” The answer may be “no,” according to follow-up information provided.Analyst Salveen Richter and colleagues laid it out:

The potential to deliver “one shot cures” is one of the most attractive aspects of gene therapy, genetically engineered cell therapy, and gene editing. However, such treatments offer a very different outlook with regard to recurring revenue versus chronic therapies... While this proposition carries tremendous value for patients and society, it could represent a challenge for genome medicine developers looking for sustained cash flow.

For a real-world example, they pointed to Gilead Sciences, which markets treatments for hepatitis C that have cure rates exceeding 90 percent. In 2015, the company’s hepatitis C treatment sales peaked at $12.5 billion. But as more people were cured and there were fewer infected individuals to spread the disease, sales began to languish. Goldman Sachs analysts estimate that the treatments will bring in less than $4 billion this year.“[Gilead]’s rapid rise and fall of its hepatitis C franchise highlights one of the dynamics of an effective drug that permanently cures a disease, resulting in a gradual exhaustion of the prevalent pool of patients,” the analysts wrote. The report noted that diseases such as common cancers—where the “incident pool remains stable”—are less risky for business.To get around the sustainability issue overall, the report suggests that biotech companies focus on diseases or conditions that seem to be becoming more common and/or are already high-incidence. It also suggests that companies be innovative and constantly expanding their portfolio of treatments. This can “offset the declining revenue trajectory of prior assets." Lastly, it hints that, as such cures come to fruition, they could open up more investment opportunities in treatments for “disease of aging.”Ars reached out to Goldman Sachs, which confirmed the content of the report but declined to comment.This post has been updated.NTS Notes: I absolutely do feel so vindicated once again, and yet very very angry! I have been stating here for the last decade at this blog the facts that cures for so many of these so called diseases that are wrecking so many lives these days are absolutely curable.... And yet here we find the evidence that the cures are absolutely withheld from the general public for the fact that curing diseases is NOT PROFITABLE for the criminals involved in treatments rather than cures!Yes, this is so absolutely disgusting and shows how truly evil these sick bastards are....They are indeed keeping people sick rather than curing them for the fact that they can bleed the patients to death financially and make BILLIONS of dollars in profits as a result....I have long known that our present medical system is so much bullshit and that the firms and businesses behind that scam are indeed in it for nothing more than the money... Curing patients is not part of their "Business model" apparently, and therefore the longer they can keep the patient sick, the more profits for them!And yes, one of the biggest criminals out there is of course the Cancer industry.... Cures for Cancer are absolutely available for anyone that has the guts to say NO to the criminal money making 'treatments' that will kill the patient eventually.....  Billions of dollars in profits for these criminals running the Cancer industry with their fraud 'treatments' is obviously "good for business" but not for the patients themselves...I do hope that this is an eye opener for everyone, and should once again back up everything that I have stated for years about how the "medical industry" is run by GREEDY criminals that are in it for their own personal gain and PROFITS.... People need to stand up to these criminals and put an end to their evil ways...More to comeNTS